Studies in type 2 diabetic persons suggest a similar effect to subcutaneous insulin (16), with some evidence of less weight gain and hypoglycemia (17).
Studies comparing type 2 diabetic persons treated with once-daily glargine versus preprandial inhaled insulin suggest similar improvement in glycemia.